Attached files
file | filename |
---|---|
EX-31.1 - EX-31.1 - ARIAD PHARMACEUTICALS INC | d34431dex311.htm |
EX-31.2 - EX-31.2 - ARIAD PHARMACEUTICALS INC | d34431dex312.htm |
10-Q - FORM 10-Q - ARIAD PHARMACEUTICALS INC | d34431d10q.htm |
Exhibit 32.1
Certification
Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
(Subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code)
Pursuant to section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of section 1350, chapter 63 of title 18, United States Code), each of the undersigned officers of ARIAD Pharmaceuticals, Inc., a Delaware corporation (the Company), does hereby certify, to such officers knowledge, that:
The Quarterly Report on Form 10-Q for the period ended June 30, 2015 (the Form 10-Q) of the Company fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, and the information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Company.
Date: August 7, 2015 | /s/ Harvey J. Berger, M.D | |||||
Harvey J. Berger, M.D. | ||||||
Chairman and Chief Executive Officer | ||||||
Date: August 7, 2015 | /s/ Edward M. Fitzgerald | |||||
Edward M. Fitzgerald | ||||||
Executive Vice President, Chief Financial Officer |